Revenue | ₹33.50Cr |
Net Profits | ₹3.68Cr |
Net Profit Margins | 10.99% |
Indo US Bio-Tech Ltd’s revenue jumped 109.64% since last year same period to ₹33.50Cr in the Q4 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 42.07% jump in its revenue since last 3-months.
Indo US Bio-Tech Ltd’s net profit jumped 607.69% since last year same period to ₹3.68Cr in the Q4 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -27.13% fall in its net profits since last 3-months.
Indo US Bio-Tech Ltd’s net profit margin jumped 237.58% since last year same period to 10.99% in the Q4 2024-2025. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -48.71% fall in its net profit margins since last 3-months.
The revenue for Indo US Bio-Tech Ltd in the Q4 results 2024 was ₹33.50Cr.
The net profit for Indo US Bio-Tech Ltd in the Q4 results 2024 was ₹3.68Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q4 results 2024 was 10.99%.
The revenue for Indo US Bio-Tech Ltd in the Q4 results 2023 was ₹15.98Cr.
The net profit for Indo US Bio-Tech Ltd in the Q4 results 2023 was ₹0.52Cr.
The net profit margin for Indo US Bio-Tech Ltd in the Q4 results 2023 was 3.25%.